Medical News

RSS

Bracco Diagnostics implements Datalliance VMI to reduce stockouts and maximize inventory investment

Kimberly Cox, Bracco Diagnostics Director of Supply Chain Operations, said, "Our goal with VMI is to expand the service we offer to our large healthcare customers. By assisting with the inventory replenishment process we will help our customers be more efficient by addressing mutual objectives such as reducing stockouts and maximizing inventory investment.

20 Jan 2010

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the “RNA Silencing: Mechanism, Biology, and Application” Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam’s therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington’s disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.

20 Jan 2010

iWorx launches a family of cardiovascular research products

iWorx, a developer of advanced physiology research and teaching tools, has launched a family of cardiovascular research products used to assess cardiac performance and hemodynamics, both in vivo and in vitro.

20 Jan 2010

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.

20 Jan 2010

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) and BD (Becton, Dickinson and Company) announced today an innovative program aimed at improving the treatment of type 1 diabetes by developing novel insulin delivery products to enhance the use of insulin pumps.

From BD (Becton, Dickinson and Company) 20 Jan 2010

European Breast Cancer Conference in Barcelona, Spain

The 7th European Breast Cancer Conference (EBCC-7) will be held in Barcelona, Spain (Centre Convencions Internacional (CCIB - FORUM), Rambla Prim 1-17, ES-08019) from Wednesday 24 - Saturday 27 March 2010.

20 Jan 2010

Hoyer: Senate health bill 'clearly better than nothing'

"House Majority Leader Steny Hoyer (D-Md.) on Tuesday said passing the Senate healthcare bill would be 'clearly better than nothing,'" The Hill reports. Though Tuesday's special election in Massachusetts could end Democrats "filibuster-proof majority" in the Senate, Hoyer said, "moving ahead on healthcare is essential" (Allen, 1/19).

20 Jan 2010

LaserBand chooses Premier Purchasing Partners as sole source provider for proprietary patient IDs

LaserBand LLC, a worldwide leader in patient identification wristbands, was awarded a contract with Premier Purchasing Partners, L.P. to be the sole source provider for proprietary patient identification (ID) bands and related products.

20 Jan 2010

Studies explore consequences of sexual abuse

Half of sexual abuse survivors wait up to five years before disclosing they were victimized, according to a collaborative study from the Universit- de Montr-al, the Universit- du Qu-bec - Montr-al and the Universit- de Sherbrooke published in The Canadian Journal of Psychiatry.

20 Jan 2010

Bederra in preliminary discussions to acquire Home Healthcare Company

Bederra Corporation, a Houston, Texas-based, diversified medical services provider announced today that it is in preliminary discussions to acquire a Home Healthcare Company.

20 Jan 2010

LEO Pharma launches psoriasis franchise in the U.S.

Denmark-based LEO Pharma, a global leader in dermatology and critical care, announced its official launch in the U.S. Headquartered in Parsippany, New Jersey, LEO Pharma U.S. will be one of the largest individual operations in the pharmaceutical company’s network of worldwide affiliates and is expected to contribute significantly to the company revenues in 2010.

20 Jan 2010

Massachusetts' Senate election could shape health reform's endgame

"Democrat Martha Coakley's struggle to stave off a potentially devastating defeat in Tuesday's special Senate election in Massachusetts marks a critical turning point in the year-long debate about health-care reform."

20 Jan 2010

Liquidia Technologies completes $20M Series C financing round

Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.

20 Jan 2010

Erectile dysfunction can be strongly related to the development of CVD

In the first study of its kind, New England Research Institutes, Inc. (NERI) in collaboration with the Division of Cardiology, San Francisco General Hospital and the University of California, San Francisco tested whether erectile dysfunction (ED) can be used to reclassify patients according to their future risk of developing cardiovascular disease (CVD) beyond traditional risk factors (such as smoking, high blood pressure, high cholesterol, etc).

20 Jan 2010

News reports question health reform provisions, forecast legal issues

News reports explore remaining issues in Congress' health overhaul negotiations.

20 Jan 2010

Combination treatment strategies may benefit patients with non-small cell lung cancer

Even when their tumors are shrinking in response to therapy, some non-small cell lung cancer (NSCLC) patients have a scattering of cancer cells that are undeterred by the drug, causing the tumor to resume its growth, Dana-Farber Cancer Institute and Massachusetts General Hospital (MGH) Cancer Center scientists report in the January issue of Cancer Cell.

20 Jan 2010

Media outlets examine efforts to develop malaria vaccines

Scientists have identified a group of proteins they say could form the basis of a malaria vaccine, Australia's ABC News reports. "However, they say more laboratory work and clinical trials need to be done, with a vaccine at least 10 years away," the news service reports (Macey, 1/19).

20 Jan 2010

Patient enrollment for Phase 2B clinical study of Oramed Pharmaceuticals' ORMD-0801 completed

Oramed Pharmaceuticals Inc. announced today the completion of patient enrollment in the Phase 2B clinical study of its oral insulin capsule, ORMD-0801.

20 Jan 2010

Neomend receives premarket approval from FDA for ProGEL Pleural Air Leak Sealant

Neomend, Inc., an innovator in sealant and adhesion-prevention products for the surgical marketplace, announced it has received premarket approval from the U.S. Food and Drug Administration (FDA) for the company’s ProGEL™ Pleural Air Leak Sealant.

20 Jan 2010

HTDS announces possible merger with EU-based, stem-cell research company

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica BioChem want to point the shareholders back to the press release from Oct 29, 2009, where the company announced news about a possible merger with a EU based, stem-cell research company.

20 Jan 2010

Medical News

Bracco Diagnostics implements Datalliance VMI to reduce stockouts and maximize inventory investment

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

iWorx launches a family of cardiovascular research products

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

European Breast Cancer Conference in Barcelona, Spain

Hoyer: Senate health bill 'clearly better than nothing'

LaserBand chooses Premier Purchasing Partners as sole source provider for proprietary patient IDs

Studies explore consequences of sexual abuse

Bederra in preliminary discussions to acquire Home Healthcare Company

LEO Pharma launches psoriasis franchise in the U.S.

Massachusetts' Senate election could shape health reform's endgame

Liquidia Technologies completes $20M Series C financing round

Erectile dysfunction can be strongly related to the development of CVD

News reports question health reform provisions, forecast legal issues

Combination treatment strategies may benefit patients with non-small cell lung cancer

Media outlets examine efforts to develop malaria vaccines

Patient enrollment for Phase 2B clinical study of Oramed Pharmaceuticals' ORMD-0801 completed

Neomend receives premarket approval from FDA for ProGEL Pleural Air Leak Sealant

HTDS announces possible merger with EU-based, stem-cell research company

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News